Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02354586
Title A Study of Niraparib in Patients With Ovarian Cancer Who Have Received at Least Three Previous Chemotherapy Regimens
Acronym QUADRA
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.